Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) is a non-profit organization based in Annapolis, Maryland. With 51 employees, PPTA is dedicated to representing the interests of private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies, as well as the collectors of source plasma used for fractionation. PPTA focuses on ensuring broad and reliable access to plasma-derived medicinal products, prioritizing the well-being of both patients and plasma donors. They work globally to advocate for patient access to these therapies, engage in constructive dialogue with regulatory agencies, and collaborate with patient advocacy organizations. The organization also plays a crucial role in administering standards and programs that guarantee the quality and safety of plasma collection and manufacturing processes, safeguarding both donors and patients. PPTA actively works to improve the reliable availability of plasma, advocate for global sufficiency, pioneer plasma safety and manufacturing quality, and support donor well-being. For more information about the Plasma Protein Therapeutics Association, visit their website at pptaglobal.org.